Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Clinical trial NCT02281760 · COMPLETED
Trial details
- NCT number
- NCT02281760
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-08-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.